Lexicon Pharmaceuticals, Inc. (LXRX) News
Track canonical SquawkNews coverage tagged to LXRX, Lexicon Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
LXRX - Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
LXRX - Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
EARNINGS | Aug 06, 2026, 11:30 AM UTC
L
LXRX - Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
LXRX - Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
EARNINGS | Jul 30, 2026, 12:31 PM UTC
L
LXRX - Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and
LXRX - Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
EQUITY | Jul 27, 2026, 12:30 PM UTC
L
LXRX Remain bullish ahead of SONATA-HCM – expected to be a major stock-moving event @ Piper
LXRX Remain bullish ahead of SONATA-HCM – expected to be a major stock-moving event @ Piper
EQUITY | Jul 24, 2026, 01:12 PM UTC